Clay B. Siegall - 13 Dec 2023 Form 3 Insider Report for Tourmaline Bio, Inc. (TRML)

Role
Director
Signature
/s/ Brad Middlekauff, Attorney-in-Fact
Issuer symbol
TRML
Transactions as of
13 Dec 2023
Net transactions value
$0
Form type
3
Filing time
15 Dec 2023, 16:21:42 UTC
Previous filing
04 Oct 2023
Next filing
08 Mar 2024

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney No Table I or Table II securities beneficially owned